Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
Condition: Malignant Pleural Mesothelioma Interventions: Diagnostic Test: E-Nose testing; Diagnostic Test: Research blood Sponsors: Memorial Sloan Kettering Cancer Center; UNIVERSITY CAMPUS BIO-MEDICO, ITALY Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2023 Category: Research Source Type: clinical trials
Endocannabinoid Activity Remodulation for Psychosis Liability in Youth
Conditions: Clinical High Risk for Psychosis; Ultra High Risk for Psychosis; Attenuated Psychotic Symptoms Intervention: Dietary Supplement: Ultra-micronized Palmitoylethanolamide (PEA) Sponsors: University of Udine; National Research Council (CNR), Institute of Biomolecular Chemistry (ICB), Italy Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 14, 2023 Category: Research Source Type: clinical trials
Breathomics: May it Become an Affordable, New Tool for Early Diagnosis and Screening of Lung Cancer?
Condition: Lung Cancer Intervention: Device: Portable GC device for brath analysis Sponsors: Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari; University of Michigan; Humanitas Hospital, Italy Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Conditions: Gastric Cancer; Image; Pathology Intervention: Drug: Neoadjuvant Chemotherapy Sponsors: Chinese Academy of Sciences; Peking University Cancer Hospital & Institute; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Yunnan Cancer Hospital; Henan Cancer Hospital; Zhenjiang First People's Hospital; First Hospital of China Medical University; Cancer Hospital of Guangxi Medical University; Peking University People's Hospital; Tianjin Medical University Cancer Institute and Hospital; The First Affiliated Hospital of Zhengzho...
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Breathomics: May it Become an Affordable, New Tool for Early Diagnosis and Screening of Lung Cancer?
Condition: Lung Cancer Intervention: Device: Portable GC device for brath analysis Sponsors: Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari; University of Michigan; Humanitas Hospital, Italy Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Conditions: Gastric Cancer; Image; Pathology Intervention: Drug: Neoadjuvant Chemotherapy Sponsors: Chinese Academy of Sciences; Peking University Cancer Hospital & Institute; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Yunnan Cancer Hospital; Henan Cancer Hospital; Zhenjiang First People's Hospital; First Hospital of China Medical University; Cancer Hospital of Guangxi Medical University; Peking University People's Hospital; Tianjin Medical University Cancer Institute and Hospital; The First Affiliated Hospital of Zhengzho...
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Breathomics: May it Become an Affordable, New Tool for Early Diagnosis and Screening of Lung Cancer?
Condition: Lung Cancer Intervention: Device: Portable GC device for brath analysis Sponsors: Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari; University of Michigan; Humanitas Hospital, Italy Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Conditions: Gastric Cancer; Image; Pathology Intervention: Drug: Neoadjuvant Chemotherapy Sponsors: Chinese Academy of Sciences; Peking University Cancer Hospital & Institute; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Yunnan Cancer Hospital; Henan Cancer Hospital; Zhenjiang First People's Hospital; First Hospital of China Medical University; Cancer Hospital of Guangxi Medical University; Peking University People's Hospital; Tianjin Medical University Cancer Institute and Hospital; The First Affiliated Hospital of Zhengzho...
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Breathomics: May it Become an Affordable, New Tool for Early Diagnosis and Screening of Lung Cancer?
Condition: Lung Cancer Intervention: Device: Portable GC device for brath analysis Sponsors: Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari; University of Michigan; Humanitas Hospital, Italy Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Conditions: Gastric Cancer; Image; Pathology Intervention: Drug: Neoadjuvant Chemotherapy Sponsors: Chinese Academy of Sciences; Peking University Cancer Hospital & Institute; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Yunnan Cancer Hospital; Henan Cancer Hospital; Zhenjiang First People's Hospital; First Hospital of China Medical University; Cancer Hospital of Guangxi Medical University; Peking University People's Hospital; Tianjin Medical University Cancer Institute and Hospital; The First Affiliated Hospital of Zhengzho...
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
Breathomics: May it Become an Affordable, New Tool for Early Diagnosis and Screening of Lung Cancer?
Condition: Lung Cancer Intervention: Device: Portable GC device for brath analysis Sponsors: Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari; University of Michigan; Humanitas Hospital, Italy Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
Conditions: Gastric Cancer; Image; Pathology Intervention: Drug: Neoadjuvant Chemotherapy Sponsors: Chinese Academy of Sciences; Peking University Cancer Hospital & Institute; Cancer Institute and Hospital, Chinese Academy of Medical Sciences; Yunnan Cancer Hospital; Henan Cancer Hospital; Zhenjiang First People's Hospital; First Hospital of China Medical University; Cancer Hospital of Guangxi Medical University; Peking University People's Hospital; Tianjin Medical University Cancer Institute and Hospital; The First Affiliated Hospital of Zhengzho...
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials
